Comparison of Ketorolac at Three Doses in Children With Acute Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

April 24, 2025

Study Completion Date

May 6, 2025

Conditions
Acute PainAbdominal PainMigraineAppendicitis AcuteRenal ColicBiliary Colic
Interventions
DRUG

Ketorolac Tromethamine

ketorolac tromethamine, an NSAID belonging to a group of non-opioid analgesics that inhibit the synthesis of prostaglandins and thromboxanes with strong analgesic and anti-inflammatory properties. It is the only non-opioid parenteral non-sedating analgesic available for use to treat acute pain in the emergency department.

Trial Locations (2)

L8N 3Z5

McMaster University Medical Centre, Hamilton

L9H6k6

McMaster Children's Hospital, Hamilton

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT05641363 - Comparison of Ketorolac at Three Doses in Children With Acute Pain | Biotech Hunter | Biotech Hunter